Company Profile
Verrica Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- VRCA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Verrica Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
5.65 USD (+0.18%)
Close
Last updated: June 23, 2026 at 00:00
97.06M USD
Market cap
Why the stock is moving
VRCA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Verrica Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Verrica Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Verrica Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Verrica Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Verrica to Participate in the Jefferies Global Healthcare Conference
Source: Verrica Pharmaceuticals
- 03
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Source: Verrica Pharmaceuticals
- 04
Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results
Source: Verrica Pharmaceuticals
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Verrica Pharmaceuticals (VRCA)?
Verrica Pharmaceuticals (VRCA) most recently closed at 5.65 USD, a +0.18% move versus the previous session.
What is the market cap of Verrica Pharmaceuticals (VRCA)?
Verrica Pharmaceuticals currently has a market capitalization of 97.06M USD on BioPharmSignal.
What does Verrica Pharmaceuticals do?
Verrica Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is VRCA stock listed?
Verrica Pharmaceuticals (VRCA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Verrica Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Verrica?
Verrica Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Verrica Pharmaceuticals targeting with Verrica?
Verrica Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Verrica Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.